Short-term Existential Behavioural Therapy for Informal Caregivers of Palliative Patients: a Randomised Controlled Trial

August 12, 2019 updated by: Martin Fegg, Ludwig-Maximilians - University of Munich
The purpose of the study is to test the effectiveness of a short-term manualised individual psychotherapy, called Existential Behavioural Therapy (EBT), to prevent depression in informal caregivers of palliative patients.

Study Overview

Status

Completed

Conditions

Detailed Description

The investigators have developed and pilot-tested a short-term manualised individual psychotherapy, called Existential Behavioural Therapy (EBT), to reduce psychological distress in informal caregivers of palliative patients. The investigators propose to conduct a two-arm randomised controlled trial (RCT) to test the effectiveness of EBT against usual care for the reduction of distress and the promotion of quality of life.

Two one-to-one manualised psychotherapeutic sessions will be compared to a treatment-as-usual control group.Treatment-as-usual includes two supportive sessions.

The design will be an unblinded RCT consisting of two conditions (EBT and Treatment-as-usual), with assessment at pre- and post-treatment and follow-ups at four weeks and six months. The trial will take place in the Clinic of Palliative Care, University of Munich (Klinik und Poliklinik für Palliativmedizin der LMU München).

Study Type

Interventional

Enrollment (Actual)

130

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Munich, Germany
        • Ludwig Maximilians University Munich

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • ≥ 21 years of age
  • informal caregivers of palliative patients at last stage of life and during bereavement;
  • fluent German language skills

Exclusion Criteria:

  • psychiatric conditions such as schizophrenic disorder, psychotic disorder etc.;
  • pronounced cognitive impairment e.g. delirium, dementia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: EBT
participants assigned to the intervention arm will receive 2 manualised therapy sessions with focus on mindfulness and activating resources delivered by trained therapists at the Clinic of Palliative Care
Experimental: Treatment-as-usual
participants assigned to the treatment-as-usual arm will receive 2 supportive sessions delivered by trained therapists at the Clinic of Palliative Care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Health Questionnaire-9 (PHQ-9)
Time Frame: Baseline; Post-treatment; 4 weeks follow-up; 6 months follow-up
A reliable and valid 9-item measure of depression
Baseline; Post-treatment; 4 weeks follow-up; 6 months follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Positive and Negative Affect Scale (PANAS; Watson et al., 1988)
Time Frame: Baseline; Post-treatment; 4 weeks follow-up; 6 months follow-up
two mood scales, one that measures positive affect and the other which measures negative affect
Baseline; Post-treatment; 4 weeks follow-up; 6 months follow-up
Satisfaction with Life Scale (SWLS; Diener et al., 1985)
Time Frame: Baseline; Post-treatment; 4 weeks follow-up; 6 months follow-up
a short 5-item instrument designed to measure global cognitive judgments of satisfaction with life
Baseline; Post-treatment; 4 weeks follow-up; 6 months follow-up
World Health Organisation Quality-of-Life Scale (WHOQOL-BREF; Angermeyer et al., 2000)
Time Frame: Baseline; Post-treatment; 4 weeks follow-up; 6 months follow-up
an abbreviated 26-item generic Quality of Life Scale developed through the World Health Organisation measuring physical health, psychological health, social relationships, and environment
Baseline; Post-treatment; 4 weeks follow-up; 6 months follow-up
Numeric rating scale for mental stress and quality of life (NRS, range 0-10)
Time Frame: Baseline; Post-treatment; 4 weeks follow-up; 6 months follow-up
a numeric scale used for the subjective measurement of mental stress and quality of life
Baseline; Post-treatment; 4 weeks follow-up; 6 months follow-up
Generalised Anxiety Disorders-7 (GAD-7; Spitzer et al., 2006)
Time Frame: Baseline; Post-treatment; 4 weeks follow-up; 6 months follow-up
a 7-item self-report measure designed to screen and assess the severity of generalised anxiety disorder symptoms
Baseline; Post-treatment; 4 weeks follow-up; 6 months follow-up
Fragebogen zur Inanspruchnahme medizinischer und nicht-medizinischer Versorgungsleistungen im Alter (FIMA; Seidl et al., 2014)
Time Frame: Baseline; 6 months follow-up
a german questionnaire for health-related resource use
Baseline; 6 months follow-up
German version of the NCCN distress-thermometer (Mehnert et al., 2005)
Time Frame: Baseline; Post-treatment; 4 weeks follow-up; 6 months follow-up
a subjective measurement of distress on a 0-10 scale
Baseline; Post-treatment; 4 weeks follow-up; 6 months follow-up
General Health Questionnaire (GHQ-12, Goldberg et al., 1972)
Time Frame: Baseline; Post-treatment; 4 weeks follow-up; 6 months follow-up
a 12-item self-report measure of psychological morbidity
Baseline; Post-treatment; 4 weeks follow-up; 6 months follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Martin Fegg, Dr., Klinik und Poliklinik für Palliativmedizin, Ludwig Maximilians Universität München

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2015

Primary Completion (Actual)

August 1, 2018

Study Completion (Actual)

January 1, 2019

Study Registration Dates

First Submitted

December 19, 2014

First Submitted That Met QC Criteria

December 23, 2014

First Posted (Estimate)

December 24, 2014

Study Record Updates

Last Update Posted (Actual)

August 14, 2019

Last Update Submitted That Met QC Criteria

August 12, 2019

Last Verified

August 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 545-12

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on EBT

Subscribe